Paras Healthcare IPO GMP today is Rs 15. Investors can use this GMP along with price band and subscription status for a better IPO review.
Open
Mainboard IPO
PARASHLTH
Paras Healthcare IPO GMP Today
Paras Healthcare operates a network of multi-specialty tertiary care hospitals under the “Paras Health” brand, primarily focused on the healthcare markets of North India and East India. The company’s core business involves providing advanced healthcare services, including complex quaternary care and specialized therapeutic treatments. It manages eight operational hospitals across cities such as Gurugram, Patna, Panchkula, Ranchi, Udaipur, Srinagar, Darbhanga, and Kanpur, with a total bed capacity of 2,211 beds as of June 30, 2026. Paras Healthcare generates the majority of its revenue from in-patient department services, which include consultations, surgeries, and specialized treatments. The company’s revenue is heavily driven by six core clinical specialties: cardiac sciences, oncology, neurosciences, gastro sciences, orthopedics and sports injury, and renal sciences. Additionally, the company generates a smaller portion of its income through in-house pharmacy sales and outpatient consultations.
- IPO Price Band
- ₹660.00 - ₹693.00
- Lot Size
- 21 Shares
- Bidding Closes
- 23 Oct 2026
- Listing Date
- 28 Oct 2026
Current GMP Status
₹15
+2.16% vs upper band
Est. Listing Gain
+2.16%
Last Trend
22 Oct 2026
Listing Price
Est. ₹708
Retail Entry
₹14,553
IPO Details
Complete IPO information
| IPO Open Date | 21 Oct 2026 |
|---|---|
| IPO Close Date | 23 Oct 2026 |
| IPO Price Band | ₹660.00 - ₹693.00 |
| Lot Size | 21 Shares |
| Current GMP | ₹15 |
| Estimated Listing Gain | +2.16% |
| Issue Size | Approx ₹1,450 Cr |
| Fresh Issue | Approx ₹500 Cr |
| Issue Type | Mainboard |
| IPO Listing | BSE, NSE |
| Retail Quota | TBA |
| Registrar | MUFG Intime India Pvt. Ltd. |
| Overall Subscription | TBA |
| Minimum Investment | ₹14,553 |
| DRHP Draft Prospectus | |
| RHP Draft Prospectus |
Analysis
IPO Snapshot & Investor Takeaways
At the upper end of its price band, Paras Healthcare is priced at ₹693 per share. With a minimum lot size of 21 shares, a retail investor applying for one lot would need approximately ₹14,553 to participate in this Mainboard issue.
The latest recorded Grey Market Premium for Paras Healthcare stands at ₹15, implying an estimated listing gain of around 2.16% over the issue price if it holds until listing. This is down ₹35 from its previously recorded level. GMP reflects informal grey-market sentiment rather than a guaranteed outcome, and can change at any point until the day of listing.
Mainboard IPOs list on the main platform of BSE/NSE, typically involve larger issue sizes, and draw participation across retail, HNI and institutional (QIB) investor categories.
Timeline
IPO roadmap at a glance
✓
Bidding Opens
21 Oct 2026
02
Bidding Closes
23 Oct 2026
03
Allotment Next
26 Oct 2026
04
Listing
28 Oct 2026
Grey Market Premium
Daily GMP status
| Date | GMP | Change | Gain |
|---|---|---|---|
| 22 Oct 2026 | ₹15.00 | -₹35.00 | 2.16% |
| 21 Oct 2026 | ₹50.00 | -₹45.00 | 7.22% |
| 20 Oct 2026 | ₹95.00 | - | 13.71% |
| 19 Oct 2026 | ₹95.00 | - | 13.71% |
| 18 Oct 2026 | ₹95.00 | - | 13.71% |
| 17 Oct 2026 | ₹95.00 | +₹5.00 | 13.71% |
| 16 Oct 2026 | ₹90.00 | -₹25.00 | 12.99% |
| 15 Oct 2026 | ₹115.00 | +₹40.00 | TBA |
| 14 Oct 2026 | ₹75.00 | - | 10.82% |
Swipe to see more →
Market Lot
Application size breakdown
| Category | Lots | Shares | Amount |
|---|---|---|---|
| Retail Minimum | 1 Lot | 21 | ₹14,553 |
| Retail Maximum | 13 Lot | 273 | ₹1,89,189 |
| S-HNI Minimum | 14 Lot | 294 | ₹2,03,742 |
| S-HNI Maximum | 68 Lot | 1,428 | ₹9,89,604 |
| B-HNI Minimum | 69 Lot | 1,449 | ₹10,04,157 |
Swipe to see more →
Fund Utilization
Objects of the Issue & Official Documents
Analysis
Paras Healthcare IPO Dates
| Particular | Dates |
|---|---|
| IPO Open Date | 21 Oct 2026 |
| IPO Close Date | 23 Oct 2026 |
| Basis of Allotment | 26 Oct 2026 |
| Refunds | 27 Oct 2026 |
| Credit to Demat Account | 27 Oct 2026 |
| IPO Listing Date | 28 Oct 2026 |
Note: The timeline for Paras Healthcare IPO is tentative and subject to change.
Analysis
Paras Healthcare Objects of the Issue & Utilisation of Proceeds
| Purpose | Crores |
|---|---|
| Repayment or prepayment of certain Company borrowings | 320.9 (64.18%) |
| Investment in Subsidiary PMHPL for borrowing repayment | 54.1 (10.82%) |
| General Corporate Purposes | 125 (25%) |
Note: Objectives are as specified in the DRHP/RHP documents of Paras Healthcare.
Analysis
Paras Healthcare Company Financials
| Period | Revenue | Expense | PAT | Assets |
|---|---|---|---|---|
| 2024 | 1151.02 Cr. | 1144.39 Cr. | 15.33 Cr. | 14,776.58 Cr. |
| 2025 | 1314.21 Cr. | 1364.24 Cr. | 57.99 Cr. | 18,104.51 Cr. |
| 2026 | 1628.79 Cr. | 1552.75 Cr. | 43.83 Cr. | 20,711.41 Cr. |
| Jun 2026 | 478.75 Cr. | 430.63 Cr. | 49.68 Cr. | 22,028.78 Cr. |
Note: Financial numbers for Paras Healthcare are in ₹ Crores unless stated otherwise.
Analysis
Paras Healthcare Company Valuation – FY2026
| KPI | Values |
|---|---|
| ROE | 12.98% |
| ROCE | 10.76% |
| EBITDA Margin | 20.60% |
| PAT Margin | 2.69% |
| Debt to Equity Ratio | 3.53 |
| Earning Per Share (EPS) | 4.34 (Basic) |
| Price/Earning P/E Ratio | - |
| Return on Net Worth (RoNW) | 12.98% |
| Net Asset Value (NAV) | 39.11 |
Note: Valuation KPIs for Paras Healthcare are computed for FY2026.
Analysis
Paras Healthcare IPO Peer Group Comparison
| Company | EPS | PE Ratio | RoNW % | NAV | Income |
|---|---|---|---|---|---|
| Aster DM Healthcare Limited | 7.53 | 95.90 | 9.70% | 88.32 | 4,643.22 Cr. |
| Apollo Hospitals Enterprise Limited | 135.04 | 60.02 | 21.95% | 657.58 | 25,228.50 Cr. |
| Fortis Healthcare Limited | 13.80 | 67.31 | 11.08% | 131.07 | 9,127.84 Cr. |
| Global Health Limited | 20.71 | 56.55 | 15.15% | 147.06 | 4,410.30 Cr. |
| Jupiter Lifeline Hospitals Limited | 29.59 | 43.98 | 13.41% | 235.50 | 1,499.79 Cr. |
| Krishna Institute of Medical Sciences Limited | 6.03 | 124.98 | 11.01% | 56.17 | 3,904.60 Cr. |
| Max Healthcare Institute Limited | 14.83 | 63.59 | 14.33% | 109.53 | 8,373.45 Cr. |
| Narayana Hrudayalaya Limited | 39.67 | 48.00 | 19.74% | 222.02 | 7,896.04 Cr. |
| Yatharth Hospital and Trauma Care Services Limited | 18.20 | 43.56 | 10.36% | 184.79 | 1,207.17 Cr. |
Note: Peer group comparisons for Paras Healthcare are sourced from DRHP filings.
Comparison
Paras Healthcare IPO vs other open IPOs
| IPO | Issue price | GMP | Subscribed | Closes |
|---|---|---|---|---|
| Paras Healthcare This IPO Mainboard | ₹693 | ₹15 (+2.2%) | - | 23 Oct |
| Jio Platforms Compare Mainboard | ₹1,119 | ₹241 (+21.5%) | 1.21x | 23 Oct |
| EAAA India Alternatives Compare Mainboard | ₹1,665 | TBA | - | 28 Oct |
| BLS Polymers Compare Mainboard | ₹150 | ₹29 (+19.3%) | - | 29 Oct |
| SFC Environmental Technologies Compare Mainboard | ₹330 | ₹21 (+6.4%) | - | 29 Oct |
| Bombay Coated & Special Steels Compare Mainboard | TBA | TBA | - | 02 Nov |
Open and upcoming IPOs, same board first. Compare with Another IPO
Comparison
Compare Paras Healthcare IPO with similar IPOs
FAQ
Paras Healthcare IPO FAQs
Paras Healthcare IPO price band is Rs 660.00 to Rs 693.00. Check the latest issue price, lot size and GMP together before applying.
Paras Healthcare IPO open date is 21 Oct 2026, close date is 23 Oct 2026, and listing date is 28 Oct 2026.
Paras Healthcare IPO lot size is 21 shares. The minimum retail investment is Rs 14,553.
Paras Healthcare is classified as a Mainboard IPO. This helps investors quickly understand the issue category and exchange segment.
Paras Healthcare IPO subscription status currently shows Subscription data is currently awaited.
Paras Healthcare operates a network of multi-specialty tertiary care hospitals under the “Paras Health” brand, primarily focused on the healthcare markets of North India and East India. The company’s core business involves providing advanced healthcare services, including complex quaternary care and specialized therapeutic treatments. It manages eight operational hospitals across cities such as Gurugram, Patna, Panchkula, Ranchi, Udaipur, Srinagar, Darbhanga, and Kanpur, with a total bed capacity of 2,211 beds as of June 30, 2026. Paras Healthcare generates the majority of its revenue from in-patient department services, which include consultations, surgeries, and specialized treatments. The company’s revenue is heavily driven by six core clinical specialties: cardiac sciences, oncology, neurosciences, gastro sciences, orthopedics and sports injury, and renal sciences. Additionally, the company generates a smaller portion of its income through in-house pharmacy sales and outpatient consultations.
Paras Healthcare IPO issue size is TBA and the expected allotment date is 26 Oct 2026.
Community discussion
Comments
Share a useful question or insight about Paras Healthcare.
Leave a comment
Your email address will not be published. All comments and replies are reviewed before appearing.
Loading comments...